ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
The evolutionary trajectory of epigenomics in adult glioma (2021)
Datta, Indrani; Pereira, Tathiane Maistro Malta; Sabedot, Thais Sarraf; She, Ruicong; Iavarone, Antonio; Noushmehr, Houtan; Poisson, Laila M.
Source: Cancer Research. Conference titles: AACR Annual Meeting 2021. Unidades: FCFRP, FMRP
Subjects: GLIOMA, SISTEMA NERVOSO CENTRAL, DADOS DE SEQUÊNCIA MOLECULAR, GENOMAS, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DATTA, Indrani et al. The evolutionary trajectory of epigenomics in adult glioma. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-2085. Acesso em: 11 maio 2024. , 2021
APA
Datta, I., Pereira, T. M. M., Sabedot, T. S., She, R., Iavarone, A., Noushmehr, H., & Poisson, L. M. (2021). The evolutionary trajectory of epigenomics in adult glioma. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-2085
NLM
Datta I, Pereira TMM, Sabedot TS, She R, Iavarone A, Noushmehr H, Poisson LM. The evolutionary trajectory of epigenomics in adult glioma [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 maio 11 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2085
Vancouver
Datta I, Pereira TMM, Sabedot TS, She R, Iavarone A, Noushmehr H, Poisson LM. The evolutionary trajectory of epigenomics in adult glioma [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 maio 11 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2085
Trabalho de evento-resumo periodico
Glioma immune microenvironment change during tumor recurrence (2021)
Pereira, Tathiane Maistro Malta; Datta, Indrani; Sabedot, Thais; She, Ruicong; Castro, Ana Valéria; Iavarone, Antonio; Poisson, Laila M.; Noushmehr, Houtan
Source: Cancer Research. Conference titles: AACR Annual Meeting 2021. Unidades: FCFRP, FMRP
Subjects: GLIOMA, GENOMAS, METILAÇÃO DE DNA, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Tathiane Maistro Malta et al. Glioma immune microenvironment change during tumor recurrence. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-2717. Acesso em: 11 maio 2024. , 2021
APA
Pereira, T. M. M., Datta, I., Sabedot, T., She, R., Castro, A. V., Iavarone, A., et al. (2021). Glioma immune microenvironment change during tumor recurrence. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-2717
NLM
Pereira TMM, Datta I, Sabedot T, She R, Castro AV, Iavarone A, Poisson LM, Noushmehr H. Glioma immune microenvironment change during tumor recurrence [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 maio 11 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2717
Vancouver
Pereira TMM, Datta I, Sabedot T, She R, Castro AV, Iavarone A, Poisson LM, Noushmehr H. Glioma immune microenvironment change during tumor recurrence [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 maio 11 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2717
Trabalho de evento-resumo periodico
Epigenomics of the glioma longitudinal analysis (glass) consortium (2020)
Sabedot, Thais; Wells, Michael; Datta, Indrani; Malta, Tathiane; Castro, Ana Valeria; Poisson, Laila M; Verhaak, Roel; Iavarone, Antonio; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais et al. Epigenomics of the glioma longitudinal analysis (glass) consortium. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.308. Acesso em: 11 maio 2024. , 2020
APA
Sabedot, T., Wells, M., Datta, I., Malta, T., Castro, A. V., Poisson, L. M., et al. (2020). Epigenomics of the glioma longitudinal analysis (glass) consortium. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.308
NLM
Sabedot T, Wells M, Datta I, Malta T, Castro AV, Poisson LM, Verhaak R, Iavarone A, Noushmehr H. Epigenomics of the glioma longitudinal analysis (glass) consortium [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii75.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noaa215.308
Vancouver
Sabedot T, Wells M, Datta I, Malta T, Castro AV, Poisson LM, Verhaak R, Iavarone A, Noushmehr H. Epigenomics of the glioma longitudinal analysis (glass) consortium [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii75.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noaa215.308
Trabalho de evento-resumo periodico
Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon (2020)
Tesileanu, C. Mircea S.; Van den Bent, Martin; Sabedot, Thais; Sanson, Marc; Brandes, Alba; Wick, Wolfgang; Clement, Paul; Erridge, Sarah; Vogelbaum, Michael; Nowak, Anna; Baurain, Jean; Mason, Warren; Wheeler, Helen; Weller, Michael; Heer, Iris de; Dubbink, Hendrikus; Kros, Johan M; Aldape, Kenneth; Wesseling, Pieter; Golfinopoulos, Vassilis; Gorlia, Thierry; Baumert, Brigitta; Noushmehr, Houtan ; French, Pim
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, RADIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TESILEANU, C. Mircea S. et al. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.693. Acesso em: 11 maio 2024. , 2020
APA
Tesileanu, C. M. S., Van den Bent, M., Sabedot, T., Sanson, M., Brandes, A., Wick, W., et al. (2020). Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.693
NLM
Tesileanu CMS, Van den Bent M, Sabedot T, Sanson M, Brandes A, Wick W, Clement P, Erridge S, Vogelbaum M, Nowak A, Baurain J, Mason W, Wheeler H, Weller M, Heer I de, Dubbink H, Kros JM, Aldape K, Wesseling P, Golfinopoulos V, Gorlia T, Baumert B, Noushmehr H, French P. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii166.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noaa215.693
Vancouver
Tesileanu CMS, Van den Bent M, Sabedot T, Sanson M, Brandes A, Wick W, Clement P, Erridge S, Vogelbaum M, Nowak A, Baurain J, Mason W, Wheeler H, Weller M, Heer I de, Dubbink H, Kros JM, Aldape K, Wesseling P, Golfinopoulos V, Gorlia T, Baumert B, Noushmehr H, French P. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii166.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noaa215.693
Trabalho de evento-resumo periodico
Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning (2019)
Snyder, James; Wells, Michael; Poisson, Laila; Kalkanis, Steven; Noushmehr, Houtan ; Robin, Adam
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: ENSAIO CLÍNICO, MENINGIOMA, GLÂNDULA PITUITÁRIA, NEOPLASIAS CEREBRAIS, ASTROCITOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SNYDER, James et al. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.558. Acesso em: 11 maio 2024. , 2019
APA
Snyder, J., Wells, M., Poisson, L., Kalkanis, S., Noushmehr, H., & Robin, A. (2019). Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.558
NLM
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noz175.558
Vancouver
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning [Internet]. Neuro-oncology. 2019 ; 21 vi133.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noz175.558
Trabalho de evento-resumo periodico
Active transcription start sites of meningioma samples associated with risk of recurrence (2019)
Malta, Tathiane; Sabedot, Thais Sarra; Carlotti Júnior, Carlos Gilberto ; Noushmehr, Houtan
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: TRANSCRIÇÃO GÊNICA, MENINGIOMA, NEOPLASIAS CEREBRAIS, EPIGÊNESE GENÉTICA, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane et al. Active transcription start sites of meningioma samples associated with risk of recurrence. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.460. Acesso em: 11 maio 2024. , 2019
APA
Malta, T., Sabedot, T. S., Carlotti Júnior, C. G., & Noushmehr, H. (2019). Active transcription start sites of meningioma samples associated with risk of recurrence. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.460
NLM
Malta T, Sabedot TS, Carlotti Júnior CG, Noushmehr H. Active transcription start sites of meningioma samples associated with risk of recurrence [Internet]. Neuro-oncology. 2019 ; 21 vi110.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noz175.460
Vancouver
Malta T, Sabedot TS, Carlotti Júnior CG, Noushmehr H. Active transcription start sites of meningioma samples associated with risk of recurrence [Internet]. Neuro-oncology. 2019 ; 21 vi110.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noz175.460
Trabalho de evento-resumo periodico
DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas (2019)
Wells, Michael; Sabedot, Thais Sarraf; Asmaro, Karam; Mosella, Maritza Queiroz Salas ; Malta, Tathiane; Nelson, Kevin; Snyder, James; Carvalho, Ana de; Mukherjee, Abir; Bahn, Arti; Robin, Adam; Rosenblum, Mark; Mikkelsen, Tom; Poisson, Laila; Lee, Ian; Walbert, Tobias; Kalkanis, Steven; Rock, Jack; Noushmehr, Houtan ; Chitale, Dhananjay; Castro, Anavaleria
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS, GLÂNDULA PITUITÁRIA, METILAÇÃO DE DNA, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WELLS, Michael et al. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.426. Acesso em: 11 maio 2024. , 2019
APA
Wells, M., Sabedot, T. S., Asmaro, K., Mosella, M. Q. S., Malta, T., Nelson, K., et al. (2019). DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.426
NLM
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Vancouver
Wells M, Sabedot TS, Asmaro K, Mosella MQS, Malta T, Nelson K, Snyder J, Carvalho A de, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, Walbert T, Kalkanis S, Rock J, Noushmehr H, Chitale D, Castro A. DNA methylation signatures detected in a serum-based liquid biopsy distinguish functional and invasiveness features in pituitary adenomas [Internet]. Neuro-oncology. 2019 ; 21 vi102.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noz175.426
Trabalho de evento-resumo periodico
Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma (2019)
Lee, Ian; Hunt, Rachel; Nelson, Kevin; Patil, Darshana; Datta, Vineet; Akolkar, Dadasaheb; Apurva, Sachin; Fulmali, Pooja; Puranik, Sneha; Snyder, James; Noushmehr, Houtan ; Devhare, Pradeep; Carvalho, Ana de; Datar, Rajan; Walbert, Tobias; Kalkanis, Steven
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, GLIOMA, LEUCEMIA, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEE, Ian et al. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.659. Acesso em: 11 maio 2024. , 2019
APA
Lee, I., Hunt, R., Nelson, K., Patil, D., Datta, V., Akolkar, D., et al. (2019). Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.659
NLM
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Vancouver
Lee I, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, Carvalho A de, Datar R, Walbert T, Kalkanis S. Prospective, blinded plasma based analysis for diagnosis of newly diagnosed glioma [Internet]. Neuro-oncology. 2019 ; 21 vi157–vi158.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noz175.659
Trabalho de evento-resumo periodico
Aberrant DNA methylation in regulatory genomic elements are associated with invasive behavior of pituitary macroadenomas: An integrative analysis of epigenome-wide studies (2019)
Mosella, Maritza Queiroz Salas ; Sabedot, Thais; Malta, Tathiane; Felicella, Michelle; Aho, Todd; Poisson, Laila; Carvalho, Ana de; Noushmehr, Houtan ; Rock, Jack; Castro, Ana Valeria
Source: Journal of the Endocrine Society. Conference titles: Annual Meeting of the Endocrine Society (ENDO). Unidade: FMRP
Subjects: METILAÇÃO DE DNA, NEOPLASIAS CEREBRAIS, EXPRESSÃO GÊNICA, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSELLA, Maritza Queiroz Salas et al. Aberrant DNA methylation in regulatory genomic elements are associated with invasive behavior of pituitary macroadenomas: An integrative analysis of epigenome-wide studies. Journal of the Endocrine Society. Washington: Endocrine Society. Disponível em: https://doi.org/10.1210/js.2019-OR24-5. Acesso em: 11 maio 2024. , 2019
APA
Mosella, M. Q. S., Sabedot, T., Malta, T., Felicella, M., Aho, T., Poisson, L., et al. (2019). Aberrant DNA methylation in regulatory genomic elements are associated with invasive behavior of pituitary macroadenomas: An integrative analysis of epigenome-wide studies. Journal of the Endocrine Society. Washington: Endocrine Society. doi:10.1210/js.2019-OR24-5
NLM
Mosella MQS, Sabedot T, Malta T, Felicella M, Aho T, Poisson L, Carvalho A de, Noushmehr H, Rock J, Castro AV. Aberrant DNA methylation in regulatory genomic elements are associated with invasive behavior of pituitary macroadenomas: An integrative analysis of epigenome-wide studies [Internet]. Journal of the Endocrine Society. 2019 ; 3[citado 2024 maio 11 ] Available from: https://doi.org/10.1210/js.2019-OR24-5
Vancouver
Mosella MQS, Sabedot T, Malta T, Felicella M, Aho T, Poisson L, Carvalho A de, Noushmehr H, Rock J, Castro AV. Aberrant DNA methylation in regulatory genomic elements are associated with invasive behavior of pituitary macroadenomas: An integrative analysis of epigenome-wide studies [Internet]. Journal of the Endocrine Society. 2019 ; 3[citado 2024 maio 11 ] Available from: https://doi.org/10.1210/js.2019-OR24-5
Trabalho de evento-resumo periodico
Methylation-based liquid biopsy of meningioma primary and recurrent samples (2019)
Sabedot, Thais Sarraf; Malta, Tathiane; Snyder, James; Walbert, Tobias; Lee, Ian; Kalkanis, Steven; Castro, Anavaleria; Noushmehr, Houtan
Source: Neuro-oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: MENINGIOMA, NEOPLASIAS CEREBRAIS, BIÓPSIA, BIOMARCADORES, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. Methylation-based liquid biopsy of meningioma primary and recurrent samples. Neuro-oncology. Oxford: Society for Neuro-Oncology. Disponível em: https://doi.org/10.1093/neuonc/noz175.463. Acesso em: 11 maio 2024. , 2019
APA
Sabedot, T. S., Malta, T., Snyder, J., Walbert, T., Lee, I., Kalkanis, S., et al. (2019). Methylation-based liquid biopsy of meningioma primary and recurrent samples. Neuro-oncology. Oxford: Society for Neuro-Oncology. doi:10.1093/neuonc/noz175.463
NLM
Sabedot TS, Malta T, Snyder J, Walbert T, Lee I, Kalkanis S, Castro A, Noushmehr H. Methylation-based liquid biopsy of meningioma primary and recurrent samples [Internet]. Neuro-oncology. 2019 ; 21 vi111.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noz175.463
Vancouver
Sabedot TS, Malta T, Snyder J, Walbert T, Lee I, Kalkanis S, Castro A, Noushmehr H. Methylation-based liquid biopsy of meningioma primary and recurrent samples [Internet]. Neuro-oncology. 2019 ; 21 vi111.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/noz175.463
Trabalho de evento-resumo
Epigenome analysis of pituitary adenomas define candidate master regulators (2019)
Mosella, Maritza Queiroz Salas ; Felicella, Michelle; Aho, Todd; Noushmehr, Houtan ; Castro, Ana Valeria de; Sabedot, Thais; Malta, Tathiane; Rock, Jack
Source: Programme Book. Conference titles: Conference Cancer Genomics. Unidade: FMRP
Subjects: ADENOMA, GLÂNDULA PITUITÁRIA, METILAÇÃO DE DNA, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSELLA, Maritza Queiroz Salas et al. Epigenome analysis of pituitary adenomas define candidate master regulators. 2019, Anais.. Cambridge: European Association for Cancer Research, 2019. . Acesso em: 11 maio 2024.
APA
Mosella, M. Q. S., Felicella, M., Aho, T., Noushmehr, H., Castro, A. V. de, Sabedot, T., et al. (2019). Epigenome analysis of pituitary adenomas define candidate master regulators. In Programme Book. Cambridge: European Association for Cancer Research.
NLM
Mosella MQS, Felicella M, Aho T, Noushmehr H, Castro AV de, Sabedot T, Malta T, Rock J. Epigenome analysis of pituitary adenomas define candidate master regulators. Programme Book. 2019 ;[citado 2024 maio 11 ]
Vancouver
Mosella MQS, Felicella M, Aho T, Noushmehr H, Castro AV de, Sabedot T, Malta T, Rock J. Epigenome analysis of pituitary adenomas define candidate master regulators. Programme Book. 2019 ;[citado 2024 maio 11 ]
Trabalho de evento-resumo periodico
Epigenomic glioma subtype evaluation across 31 tumor types (2017)
Mosella, Maritza; Sarraf, Thais; Malta, Tathiane; Chedraoui, Tiago; Noushmehr, Houtan; Castro, Ana Valéria
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GENÉTICA, NEOPLASIAS DO SISTEMA NERVOSO, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSELLA, Maritza et al. Epigenomic glioma subtype evaluation across 31 tumor types. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nox168. Acesso em: 11 maio 2024. , 2017
APA
Mosella, M., Sarraf, T., Malta, T., Chedraoui, T., Noushmehr, H., & Castro, A. V. (2017). Epigenomic glioma subtype evaluation across 31 tumor types. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nox168
NLM
Mosella M, Sarraf T, Malta T, Chedraoui T, Noushmehr H, Castro AV. Epigenomic glioma subtype evaluation across 31 tumor types [Internet]. Neuro-Oncology. 2017 ; 19 vi103-vi104.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/nox168
Vancouver
Mosella M, Sarraf T, Malta T, Chedraoui T, Noushmehr H, Castro AV. Epigenomic glioma subtype evaluation across 31 tumor types [Internet]. Neuro-Oncology. 2017 ; 19 vi103-vi104.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/nox168
Trabalho de evento-resumo periodico
PD-L1 expression associated with glioma molecular subtypes: clinical implications (2017)
Malta, Tathiane; Snyder, James; Kalkanis, Steven; Castro, Ana Valéria; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GENÉTICA, NEOPLASIAS DO SISTEMA NERVOSO, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane et al. PD-L1 expression associated with glioma molecular subtypes: clinical implications. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nox168. Acesso em: 11 maio 2024. , 2017
APA
Malta, T., Snyder, J., Kalkanis, S., Castro, A. V., & Noushmehr, H. (2017). PD-L1 expression associated with glioma molecular subtypes: clinical implications. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nox168
NLM
Malta T, Snyder J, Kalkanis S, Castro AV, Noushmehr H. PD-L1 expression associated with glioma molecular subtypes: clinical implications [Internet]. Neuro-Oncology. 2017 ; 19 vi126.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/nox168
Vancouver
Malta T, Snyder J, Kalkanis S, Castro AV, Noushmehr H. PD-L1 expression associated with glioma molecular subtypes: clinical implications [Internet]. Neuro-Oncology. 2017 ; 19 vi126.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/nox168
Trabalho de evento-resumo periodico
Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype (2017)
Sabedot, Thais Sarraf; Poisson, Laila; Carvalho, Ana C. de; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GENÉTICA, NEOPLASIAS DO SISTEMA NERVOSO, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nox168. Acesso em: 11 maio 2024. , 2017
APA
Sabedot, T. S., Poisson, L., Carvalho, A. C. de, & Noushmehr, H. (2017). Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype. Neuro-Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nox168
NLM
Sabedot TS, Poisson L, Carvalho AC de, Noushmehr H. Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype [Internet]. Neuro-Oncology. 2017 ; 19 vi105.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/nox168
Vancouver
Sabedot TS, Poisson L, Carvalho AC de, Noushmehr H. Depletion of 5-hydroxymethylcytosine in aggressive G-CIMP subtype [Internet]. Neuro-Oncology. 2017 ; 19 vi105.[citado 2024 maio 11 ] Available from: https://doi.org/10.1093/neuonc/nox168

USP Schools

ReP

Filtros

Authors

Subjects

Non normalized affiliation

Countries of institutions of collaboration